HHS 21 CFR PART 1306-2011 PRESCRIPTIONS《处方》.pdf
《HHS 21 CFR PART 1306-2011 PRESCRIPTIONS《处方》.pdf》由会员分享,可在线阅读,更多相关《HHS 21 CFR PART 1306-2011 PRESCRIPTIONS《处方》.pdf(13页珍藏版)》请在麦多课文档分享上搜索。
1、90 21 CFR Ch. II (4111 Edition) 1305.27 record of the second order and a copy of the statement with the record of the first order and retain them. (c) If the supplier to whom the order was directed subsequently receives the first order, the supplier must indicate that it is Not Accepted and return i
2、t to the purchaser. The purchaser must link the returned order to the record of that order and the statement. 1305.27 Preservation of electronic or-ders. (a) A purchaser must, for each order filled, retain the original signed order and all linked records for that order for two years. The purchaser m
3、ust also re-tain all copies of each unaccepted or defective order and each linked state-ment. (b) A supplier must retain each origi-nal order filled and the linked records for two years. (c) If electronic order records are maintained on a central server, the records must be readily retrievable at th
4、e registered location. 1305.28 Canceling and voiding elec-tronic orders. (a) A supplier may void all or part of an electronic order by notifying the purchaser of the voiding. If the entire order is voided, the supplier must make an electronic copy of the order, indi-cate on the copy Void, and return
5、 it to the purchaser. The supplier is not required to retain a record of orders that are not filled. (b) The purchaser must retain an electronic copy of the voided order. (c) To partially void an order, the supplier must indicate in the linked record that nothing was shipped for each item voided. 13
6、05.29 Reporting to DEA. A supplier must, for each electronic order filled, forward either a copy of the electronic order or an electronic report of the order in a format that DEA specifies to DEA within two busi-ness days. PART 1306PRESCRIPTIONS GENERAL INFORMATION Sec. 1306.01 Scope of part 1306. 1
7、306.02 Definitions. 1306.03 Persons entitled to issue prescrip-tions. 1306.04 Purpose of issue of prescription. 1306.05 Manner of issuance of prescriptions. 1306.06 Persons entitled to fill prescriptions. 1306.07 Administering or dispensing of nar-cotic drugs. 1306.08 Electronic prescriptions. 1306.
8、09 Prescription requirements for online pharmacies. CONTROLLED SUBSTANCES LISTED IN SCHEDULE II 1306.11 Requirement of prescription. 1306.12 Refilling prescriptions; issuance of multiple prescriptions. 1306.13 Partial filling of prescriptions. 1306.14 Labeling of substances and filling of prescripti
9、ons. 1306.15 Provision of prescription informa-tion between retail pharmacies and cen-tral fill pharmacies for prescriptions of Schedule II controlled substances. CONTROLLED SUBSTANCES LISTED IN SCHEDULES III, IV, AND V 1306.21 Requirement of prescription. 1306.22 Refilling of prescriptions. 1306.23
10、 Partial filling of prescriptions. 1306.24 Labeling of substances and filling of prescriptions. 1306.25 Transfer between pharmacies of pre-scription information for Schedules III, IV, and V controlled substances for refill purposes. 1306.26 Dispensing without prescription. 1306.27 Provision of presc
11、ription informa-tion between retail pharmacies and cen-tral fill pharmacies for initial and refill prescriptions of Schedule III, IV, or V controlled substances. AUTHORITY: 21 U.S.C. 821, 829, 831, 871(b), unless otherwise noted. SOURCE: 36 FR 7799, Apr. 24, 1971; 36 FR 13386, July 21, 1971, unless
12、otherwise noted. Redesignated at 38 FR 26609, Sept. 24, 1973. GENERAL INFORMATION 1306.01 Scope of part 1306. Rules governing the issuance, filling and filing of prescriptions pursuant to section 309 of the Act (21 U.S.C. 829) are set forth generally in that section and specifically by the sections
13、of this part. 1306.02 Definitions. Any term contained in this part shall have the definition set forth in section 102 of the Act (21 U.S.C. 802) or part 1300 of this chapter. 62 FR 13964, Mar. 24, 1997 VerDate Mar2010 07:57 May 04, 2011 Jkt 223073 PO 00000 Frm 00100 Fmt 8010 Sfmt 8010 Y:SGML223073.X
14、XX 223073erowe on DSK5CLS3C1PROD with CFRProvided by IHSNot for ResaleNo reproduction or networking permitted without license from IHS-,-,-91 Drug Enforcement Administration, Justice 1306.05 1306.03 Persons entitled to issue pre-scriptions. (a) A prescription for a controlled substance may be issued
15、 only by an in-dividual practitioner who is: (1) Authorized to prescribe controlled substances by the jurisdiction in which he is licensed to practice his profession and (2) Either registered or exempted from registration pursuant to 1301.22(c) and 1301.23 of this chapter. (b) A prescription issued
16、by an indi-vidual practitioner may be commu-nicated to a pharmacist by an em-ployee or agent of the individual prac-titioner. 36 FR 7799, Apr. 24, 1971, as amended at 36 FR 18732, Sept. 21, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973, as amended at 62 FR 13966, Mar. 24, 1997 1306.04 Purpose of
17、 issue of prescrip-tion. (a) A prescription for a controlled substance to be effective must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his professional practice. The responsibility for the proper prescribing and dispensing of controlled sub
18、stances is upon the pre-scribing practitioner, but a cor-responding responsibility rests with the pharmacist who fills the prescrip-tion. An order purporting to be a pre-scription issued not in the usual course of professional treatment or in legiti-mate and authorized research is not a prescription
19、 within the meaning and intent of section 309 of the Act (21 U.S.C. 829) and the person knowingly filling such a purported prescription, as well as the person issuing it, shall be subject to the penalties provided for violations of the provisions of law re-lating to controlled substances. (b) A pres
20、cription may not be issued in order for an individual practitioner to obtain controlled substances for sup-plying the individual practitioner for the purpose of general dispensing to pa-tients. (c) A prescription may not be issued for detoxification treatment or maintenance treatment, unless the pre
21、scription is for a Schedule III, IV, or V narcotic drug approved by the Food and Drug Administration specifically for use in maintenance or detoxifica-tion treatment and the practitioner is in compliance with requirements in 1301.28 of this chapter. 36 FR 7799, Apr. 24, 1971. Redesignated at 38 FR 2
22、6609, Sept. 24, 1973, and amended at 39 FR 37986, Oct. 25, 1974; 70 FR 36343, June 23, 2005 1306.05 Manner of issuance of pre-scriptions. (a) All prescriptions for controlled substances shall be dated as of, and signed on, the day when issued and shall bear the full name and address of the patient,
23、the drug name, strength, dosage form, quantity prescribed, di-rections for use, and the name, address and registration number of the practi-tioner. (b) A prescription for a Schedule III, IV, or V narcotic drug approved by FDA specifically for detoxification treatment or maintenance treat-ment must i
24、nclude the identification number issued by the Administrator under 1301.28(d) of this chapter or a written notice stating that the practi-tioner is acting under the good faith exception of 1301.28(e) of this chapter. (c) Where a prescription is for gamma-hydroxybutyric acid, the prac-titioner shall
- 1.请仔细阅读文档,确保文档完整性,对于不预览、不比对内容而直接下载带来的问题本站不予受理。
- 2.下载的文档,不会出现我们的网址水印。
- 3、该文档所得收入(下载+内容+预览)归上传者、原创作者;如果您是本文档原作者,请点此认领!既往收益都归您。
下载文档到电脑,查找使用更方便
5000 积分 0人已下载
下载 | 加入VIP,交流精品资源 |
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- HHS21CFRPART13062011PRESCRIPTIONS 处方 PDF
